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Label-free multiphoton microscopy 
reveals relevant tissue changes 
induced by alginate hydrogel 
implantation in rat spinal cord 
injury
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Magda Marečková2,4, Maria Koch2,4, Elke Leipnitz2, Gabriele Schackert2,  
Edmund Koch1,4, Michael Gelinsky  3,4, Gerald Steiner1 & Matthias Kirsch2,4
The development of therapies promoting recovery after spinal cord injury is a challenge. Alginate 
hydrogels offer the possibility to develop biocompatible implants with mechanical properties tailored 
to the nervous tissue, which could provide a permissive environment for tissue repair. Here, the effects 
of non-functionalized soft calcium alginate hydrogel were investigated in a rat model of thoracic spinal 
cord hemisection and compared to lesioned untreated controls. Open field locomotion tests were 
employed to evaluate functional recovery. Tissue analysis was performed with label-free multiphoton 
microscopy using a multimodal approach that combines coherent anti-Stokes Raman scattering to 
visualize axonal structures, two-photon fluorescence to visualize inflammation, second harmonic 
generation to visualize collagenous scarring. Treated animals recovered hindlimb function significantly 
better than controls. Multiphoton microscopy revealed that the implant influenced the injury-induced 
tissue response, leading to decreased inflammation, reduced scarring with different morphology 
and increased presence of axons. Demyelination of contralateral white matter near the lesion was 
prevented. Reduced chronic inflammation and increased amount of axons in the lesion correlated 
with improved hindlimb functions, being thus relevant for locomotion recovery. In conclusion, non-
functionalized hydrogel improved functional outcome after spinal cord injury in rats. Furthermore, 
label-free multiphoton microscopy qualified as suitable technique for regeneration studies.
Every year, between 250,000 and 500,000 people around the world suffer a spinal cord injury (SCI)1. SCI impacts 
the physical, psychological and social status of the patients and puts a substantial financial burden on them and 
national health care systems2–4. SCI results in death of neurons and destruction of white matter tracts resulting 
in major dysfunction of motor, sensory and autonomic systems. The primary injury to the spinal cord causes an 
immediate blunt or mechanical disruption of tissue structures, giving way to the secondary injury and chronic 
degeneration of nervous tissue and axons5. The subsequent events after the primary injury are a concert of com-
plex processes, which end in tissue necrosis and degeneration leading to cavity formation, with fibrotic and glial 
scarring hindering axonal elongation5. In this context, neuroprotective and regenerative strategies aiming to min-
imize propagation of secondary injury and axonal degeneration are crucial. Therapeutic approaches utilizing stem 
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cells, modulation of extracellular matrix, neurotrophic factors, as well as integrative and combinatory approaches 
have been studied6–9. Ideally, after reduction of secondary injury and creation of a regeneration-friendly environ-
ment with tissue-like mechanical properties, the axons should regrow, innervate the original target and lead to 
functional recovery.
Because of their hydrophilic character and biocompatibility, hydrogels became attractive for tissue engineer-
ing in a variety of tissues and organs10, including the nervous system11,12. Calcium-crosslinked alginate utilizes the 
electrostatic interaction of the divalent cation with the anionic polycarboxylates to form an ionically crosslinked 
network, which can also host drugs, growth factors, or cell grafts to sustain central nervous tissue regenera-
tion13,14. The implantation of porous alginate grafts into the lesion gap in transected spinal cord of young rats has 
been shown to stimulate the regrowth of myelinated and unmyelinated fibers, and the formation of electrophys-
iological active connections15–17. However, contrasting results about effects of calcium alginate hydrogels on out-
growth of neurites in vitro were reported in the past18,19, while alginate implants failed to sustain axonal growth 
in vivo in absence of functionalization20.
The stiffness of alginate hydrogels can be tailored. This is a key factor that determines implant effects. Soft low 
cross-linked alginate hydrogels, with compressive modulus in the range 0.1–1.0 kPa, are ideal for application to 
the nervous tissue21. We demonstrated that soft alginate hydrogels prepared with sub-stoichiometric concentra-
tion of Ca2+ cations support neurite growth in vitro and protect neuronal cells against oxidative stress without the 
need of functionalization18. Implantation of such alginate hydrogels in small spinal cord lesions in rats improved 
functional recovery22. Moreover, they maintain their mass and volume after immersion in saline solution23. 
Indeed, a soft calcium alginate hydrogel preparation led to implants that remained stable in a rat model of SCI up 
to six months after injury24,25, with positive effects on fibrotic scarring and contralateral demyelination25. Other 
studies confirmed that ultrasoft alginate hydrogels strongly promote neuritogenesis in vitro and showed that they 
sustain the formation of functional neuronal networks26.
Detailed monitoring of structural and histological changes after SCI is necessary to assess the neuroprotective 
and regenerative effects of therapies. Optical label-free imaging techniques constitute a powerful monitoring 
tool besides immunohistochemistry. For instance, multiphoton microscopy offers the possibility of fast imaging 
of unstained tissue based on its morphochemistry. Coherent anti-Stokes Raman scattering (CARS) microscopy 
allows label-free imaging of lipids by selectively addressing the distribution of methylene groups in the tissue27, 
and is thus able to visualize myelin sheaths structures28–30. Furthermore, CARS visualizes extra- and intracellu-
lar lipid droplets31, for example in activated macrophages that have transformed into foam cells32. Two-photon 
excited fluorescence (TPEF) enables to identify activated inflammatory cells (microglia and macrophages) in the 
central nervous system33. Second harmonic generation (SHG) visualizes collagen type I34. The combination of 
these three multiphoton imaging techniques enables a comprehensive study of SCI35. Moreover, imaging with 
multiphoton microscopy does not require incubation and washing steps, or other processing of tissue sections. 
Therefore, the technique is well suited for observation of small details and delicate tissue structures that might be 
lost during conventional staining procedures.
We report about the effects of non-functionalized soft calcium alginate hydrogel implants in a rat model of 
spinal cord hemisection. The same hydrogel formulation was already proven to sustain neurite growth in vitro18 
and to be stable in saline solution23 as well as in vivo up to six months after implantation24,25. Here, we investigated 
the functional outcome and used label-free multiphoton microscopy complemented by histologic techniques for 
detailed tissue characterization in the intermediate and chronic phase of injury. Moreover, we compared loco-
motor functions with tissue micro-morphology as shown by label-free multiphoton microscopy, with the aim to 
identify prognostic parameters and qualify this technique as diagnostic tool.
Results
Functional outcome. The hindlimb function was tested in open field from 3 days post-injury (DPI) until 
the chronic phase at 154 DPI (Fig. 1a). In the acute phase, a spinal shock with predominantly left sided parapare-
sis occurred in all rats. Ipsilateral hindlimb function improved rapidly within the first 14 days in all animals. The 
BBB (Basso Beattie and Bresnahan) score vs. DPI curves of all animals showed a steep and almost identical course 
until 7 DPI. Overall, the functional improvement in the alginate group was better than in the control group that 
did not receive any treatment from 7 DPI on, and the gap between the curves progressively widened until 28 DPI. 
Afterward, we observed stagnation in both groups.
A significant effect of treatment was confirmed by two-way repeated measures of ANOVA (P < 0.001) and 
pairwise comparisons with Bonferroni post hoc t tests showed that the mean BBB scores of alginate-treated rats 
were significantly improved at several time points.
The frequency distribution of the BBB score at selected time points is depicted in Fig. 1b and approximates in 
most cases a normal distribution. Starting at 14 DPI, more alginate-treated rats achieved BBB scores ≥13, which 
marks the onset of frequent forelimb-hindlimb coordination. This is an important component of effective loco-
motion in rats and further evidence for better recovery of treated animals.
Lesion dimension. The anatomical extent of the lesion and of tissue damage (micro-cysts) beyond the lesion 
was measured on hematoxylin-eosin (HE) stained sections (Fig. 2a,b). At 28 DPI, the lesion was larger than the 
nominal dimension of the hemimyelonectomy (∼6 mm3) in all animals, as shown in Fig. 2c. Treatment and 
control group did not display any significant difference. At 154 DPI, the lesion had shrunk below the nominal 
hemimyelonectomy dimension in a subset of control animals, while the mean lesion dimension of the treatment 
group did not change compared to the earlier time point. As a result, the mean lesion volume of the treatment 
group was significantly larger. However, animals with larger lesions did not show worse functional outcome; no 
negative correlation between lesion dimension and functions was found by analyzing the single animals, as illus-
trated in Supporting Fig. S1.
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The larger lesion volume of the treatment group was related to the presence of larger cysts. The morphology of 
the contralateral spinal cord was generally better preserved in the treatment group, while collapsing of the con-
tralateral white matter tract toward the lesion was more often observed in the control group (compare Fig. 2a,b).
SCI visualized by label-free multiphoton microscopy. Figure 3a shows the structure of injured tis-
sue and of surrounding spinal cord as visualized by label-free multiphoton microscopy of unstained rehydrated 
Figure 1. Open field behavioral tests. (a) Basso, Beattie and Bresnahan (BBB) scores of ipsilateral hindlimb 
(mean ± SD, n = 14 in each group). Bonferroni post hoc t-test, *P < 0.05, **P < 0.01, ***P < 0.001. (b) 
Frequency histograms illustrating the distribution of BBB scores at 7, 14, 21, 28, 42 and 154 DPI.
Figure 2. Morphology of the lesion. (a) Example of HE stained section of a sample of the control group at 154 
DPI. (b) Example of HE stained section of a sample of the treatment group at 154 DPI. (c) Lesion volume, two-
tailed t-test, *P = 0.04. The lesion volume included all injury-related changes visible using HE staining, namely 
scarring, interruption of continuity, and cyst formation.
www.nature.com/scientificreports/
4SCIenTIFIC REPORTS |  (2018) 8:10841  | DOI:10.1038/s41598-018-29140-z
cryosection. CARS allows the identification of white matter and axons. Myelin sheaths are characterized by high 
CARS intensity and therefore myelinated axons, indicated by arrows in Fig. 3b, can be readily distinguished from 
other nervous structures. TPEF is generated by intrinsic cytoplasmic fluorophores such as NAD(P)H, and is 
particularly intense in activated inflammatory cells, both microglia and macrophages33. These cells were found 
especially inside or nearby the injury area (arrowheads in Fig. 3c). Moreover, large cells in gray matter were char-
acterized by weak punctuate TPEF in the cytoplasm, and might represent neurons in agreement with previous 
findings36, or spinal cord astrocytes. An example of these is indicated by the arrowhead in Fig. 3b. SHG visualizes 
the dura, indicated by arrows in Fig. 3a, and the fibrotic scar at the lesion site.
Striking tissue alterations of spinal cord parenchyma, with massive accumulation of fluorescent inflammatory 
cells and dense collagenous scarring were found at the hemisection site and its immediate surroundings on the 
ipsilateral side, for a total extension not exceeding 4 mm. This focal tissue pathology is in agreement with other 
findings on spinal cord transection in rats37.
Scarring. Collagenous scarring was evaluated using the SHG signal of the label-free multiphoton images. 
The scar tended to fill the lesion in the control samples, while a thin lining of collagen typically encapsulated the 
cysts in samples of treated animals. This observation applied at 28 DPI, as well as at 154 DPI as shown in Fig. 4a,b. 
Analysis of cross sections at 154 DPI confirmed the morphological difference of scarring between the two groups. 
While in the majority of samples of the control group a dense collagen meshwork filled the lesion (Fig. 4c), cysts 
with just a thin lining of collagen were mostly observed in the treatment group (Fig. 4d). Total amount of collagen 
in the tissue was quantified on cross sections as percent of area displaying a SHG signal and is shown in Fig. 4e. 
Massive deposition of collagen was observed in many samples of the control group, but in none of the treatment 
group. However, the difference between the mean content of collagen is not statistically significant.
The orientation of collagen fibers was evaluated on longitudinal sections and was found to be significantly 
affected by the treatment, irrespective from the time point, as illustrated in Fig. 4f. While in the control group the 
main direction of collagen fibers typically displays large angles to the longitudinal axis of spinal cord, longitudinal 
alignment is evident in the treatment group, as shown by clustering of the data below 30°.
The glial scar was addressed with GFAP immunofluorescence in combination with label-free multipho-
ton microscopy. The glial scar surrounding the fibrotic scar was observed in all animals, with large inter- and 
intra-animal variability in scar extension and astrocyte density at both time points. A reduction of the glial scar 
in treated animals could not be proven. A tendency of astrocytic processes to align with the spinal cord axis was 
found in a subset of treated animals at 154 DPI. Moreover, a thinner glial scar was most often observed in combi-
nation with a thin fibrotic scar typically surrounding cystic spaces, as it can be seen in Supporting Fig. S2.
Figure 3. Spinal cord injury visualized by label-free multiphoton microscopy. RGB images obtained merging 
CARS (red), endogenous TPEF (green) and SHG (blue). (a) Longitudinal section of a sample of the control 
group at 154 DPI (HE staining of a consecutive section is shown in Fig. 2a); wm: white matter, gm: gray matter, 
arrows indicate the dura. (b) Magnification showing the tissue structure at the border between gray and white 
matter; arrows indicate myelinated axons, the arrowhead indicates a neuron. (c) Magnification showing the 
tissue structure in the lesion; arrowheads indicate inflammatory cells.
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Myelin degradation and axonal demyelination. Myelin degradation inside and around the injury at 28 
and 154 DPI was evaluated using the CARS signal of images of longitudinal spinal cord sections. The morphology 
of white matter was analyzed based on presence of ovoidal myelin fragments and lipid droplets. Myelin ovoids 
visualized by label-free chemical imaging have been shown earlier to be unequivocally associated with nerve 
degeneration38. Scores from zero to three were associated with increasing levels of degradation based on presence 
of ovoidal myelin fragments and the degree of axonal alignment, as shown in Fig. 5a. Most of the animals at 28 
DPI displayed scores between two and three, indicating strongly altered white matter morphology with myelin 
Figure 4. Fibrotic scarring. (a) Label-free multiphoton picture of a longitudinal section of a control spinal 
cord at 154 DPI. (b) Label-free multiphoton picture of a longitudinal section of a treatment sample at 154 DPI, 
with magnification of the collagenous lining of the cyst. (c) Label-free multiphoton picture of a cross section of 
a control sample at 154 DPI. (d) Label-free multiphoton picture of cross section of a treatment sample at 154 
DPI. (e) Quantification of tissue area covered by SHG-active collagen on cross sections at 154 DPI (mean ± SD). 
(f) Evaluation of collagen fiber direction on longitudinal sections at 28 and 154 DPI; the median is indicated; 
Mann-Whitney test, *P = 0.021. CARS: red, TPEF: green, SHG: blue.
Figure 5. Myelin morphology. (a) Different myelin morphology in label-free multiphoton pictures and 
associated scores. Score “zero”: normal white matter; scores 1 and 2: increasing presence of lipid droplets and 
disturbed axonal alignment; score 3: predominant lipid droplets and loss of any recognizable axonal alignment. 
CARS: red, TPEF: green, SHG: blue. (b) Myelin scores (the median is indicated).
www.nature.com/scientificreports/
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degradation (Fig. 5b). At 154 DPI, myelin degradation is resolved and residual lipid droplets were observed only 
in a few regions. All animals had scores close to or lower than one. The implant did not have any significant influ-
ence on myelin morphology at either time point.
White matter regions, in which axonal structures are visible, but exhibit much lower CARS signal, were inter-
preted as demyelination, as shown in Fig. 6a. Axonal demyelination was clearly observed on longitudinal sections 
at 28 DPI in the ipsilateral white matter close to the lesion and, in few cases, also in the contralateral white matter. 
At 154 DPI, only control animals were characterized by significant demyelination of the white matter contralat-
eral to the lesion, as revealed by analysis of CARS signal intensity on spinal cord cross-sections (Fig. 6b).
Axons within the lesion. The presence of myelinated axons in the lesion was evaluated using the CARS 
signal of images of longitudinal sections. Axons were considered to be localized in the injured area when concur-
rent presence of collagen was confirmed by the SHG signal. At 28 DPI, few scattered axons were detected in the 
external parts of the lesion of both treatment and control groups. At 154 DPI, axons were visible inside the scar-
ring tissue in both experimental groups, as well as in the thin bridges of tissue crossing the cysts in the samples 
of the treatment group, as shown in Fig. 7a. The axons and the collagen fibers in the lesion were often parallel, as 
in the example of Fig. 7b. Immunohistochemistry confirmed both observations, showing the presence of β-III 
tubulin positive structures in the tissue bridges (Fig. 7c) as well as their alignment with collagen fibers (Fig. 7d). 
Moreover, GAP 43 immunohistochemistry demonstrated the presence of sprouting axons in the tissue bridges 
crossing the cysts (Fig. 7e) and in the tissue surrounding the cysts in animals of the treatment group.
At 28 DPI, the axon number evaluated on CARS images was lower and there was no implant effect (Fig. 7f). 
At 154 DPI, three treated animals were characterized by very high axon counts, although the overall difference 
between groups was statistically not significant. Finally, the BBB score of each animal were plotted versus axon 
count and a linear regression was performed (r2 = 0.46) with positive slope significantly different from zero 
(P < 0.001), as shown in Fig. 7g. This indicates a correlation between axons and better functional performances.
Inflammation. Inflammatory cells were evaluated using the TPEF signal of label-free multiphoton images, 
based on methods validated elsewhere33. Additionally, matching between cells displaying strong endogenous 
TPEF and activated microglia/macrophages was verified by comparison with Iba1 immunohistochemisty 
(Supporting Fig. S3). At 28 DPI, fluorescent inflammatory cells accumulate in the resection cavity of control 
samples as shown in Fig. 8a, or around the implant in treatment samples as shown in Fig. 8b. Fluorescent cells at 
this time point are laden with lipid droplets and are consistent with foam cells (magnifications in Fig. 8a,b). At 154 
DPI, fewer fluorescent cells were observed in the lesion of control samples, as shown in Fig. 8c, as well as around 
the implant in treated samples. Quantitative analyses confirmed that the inflammation was significantly higher 
at 28 DPI compared to 154 DPI (Fig. 8d). The samples of treated animals displayed lower inflammation, and the 
difference compared to controls was significant at 28 DPI. A weak degree of negative correlation between extent 
of inflammation at the lesion site and hindlimb function was found (Supporting Fig. S4).
Outside the lesion, fluorescent immune cells consistent with foam cells accumulated in the dorsal median 
sulcus cranial to the lesion at 154 DPI, irrespective of the treatment (Fig. 8c). Additionally, scattered immune 
cells were detected in ipsilateral and contralateral white matter some millimeters away from the lesion, where the 
tissue morphology appears normal in all other aspects.
TPEF images of cross-sections located ∼4 mm away from the lesion were analyzed in order to refine the 
evaluation of this diffuse type of chronic inflammation, confirming high immune cell occurrence in the dorsal 
Figure 6. Axonal demyelination of contralateral white matter. (a) Demyelination observed at 28 DPI by label-
free multiphoton microscopy of a longitudinal spinal cord section of a treated animal; myelinated axons are 
visible in the upper part, demyelinated ones in the lower part; CARS: red, TPEF: green, SHG: blue. (b) CARS 
signal intensity in the contralateral white matter measured on cross sections at 154 DPI (mean ± SD, one-way 
repeated ANOVA, *P < 0.05).
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median sulcus cranial to the lesion (arrow in Fig. 8e) and sparse immune cells in the white matter, both cranial 
and caudal to the lesion (boxes in Fig. 8e). Furthermore, the analysis revealed many cells near the ventral fissure 
on the caudal sections in all samples (arrowhead in Fig. 8e).
The quantification of immune cells number in the white matter cranial and caudal to the lesion revealed a 
significantly higher number of cells in the ipsilateral white matter, as shown in Fig. 8f. Although the inflammatory 
cells were generally less in the treated samples (see also Supporting Fig. S5), the effect of implants was not statis-
tically significant. However, a relationship exists between hindlimb functions and inflammation in the chronic 
phase, as revealed by the scatter plot of BBB score vs. total number of inflammatory cells on both spinal cord sides 
shown in Fig. 8g. The linear regression indicates a correlation (r2 = 0.52) with negative slope significantly different 
from zero (P < 0.01).
Discussion
Up to date, there is no approved clinical regenerative therapy for spinal cord injury. Animal studies investigated 
mostly combined approaches incorporating stem cells, neurotrophic factors and 3D matrix/scaffolds. Besides 
the specific nuances in “readiness” to regenerate of species, a major difficulty in translating any therapeutic 
approach from the laboratory into clinical studies is the predictability of its adverse effects. Alginate hydrogels 
offer a major advantage in this context, since they are already established as biocompatible inert materials in the 
Figure 7. Axons in the lesion. (a,b) Label-free multiphoton pictures of longitudinal sections of samples of the 
treatment group at 154 DPI; CARS: red, TPEF: green, SHG: blue. Axonal structures are clearly visualized by 
CARS at high magnification. (c) Immunohistochemistry of a non-consecutive section of the sample shown in 
(a) visualized by multiphoton microscopy (red: TPEF of β-III tubulin, blue: SHG). (d) Immunohistochemistry 
of a non-consecutive section of the sample shown in (b), visualized by multiphoton microscopy (red: TPEF of 
β-III tubulin, blue: SHG). (e) GAP43 immunohistochemistry for growing axons of a non-consecutive section 
of the sample shown in (a) visualized by multiphoton microscopy (red: TPEF of GAP43, blue: SHG). (f) Axon 
counts within the lesion (mean ± SD). (g) Scatter plot of functions vs. axon counts. BBB scores indicated as 154 
DPI are the average of scores obtained for each rat between 70 and 154 DPI.
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clinical context39,40. Easy handling and modifiability prior to implantation renders them suitable for spinal cord 
laceration injuries.
Therefore, we investigated functional and morpho-chemical effects of non-functionalized soft alginate 
implants in a thoracic hemisection model in rats. We found the following implant- related effects: 1) function 
improvement starting already in the sub-acute phase; 2) thinner collagen scar, with collagen fibers more often 
longitudinally oriented; 3) increased number of myelinated axons in the lesion; 4) decreased contralateral demy-
elination; 5) reduced accumulation of inflammatory cells at the lesion; 6) decreased chronic inflammation.
Treated rats showed BBB scores that are on average two scores higher than those of control animals in the 
chronic phase. The mean BBB improvement after interventions with functionalized biomaterials in hemisection 
models retrieved in a systematic review41 is moderate as well (4.44, 95% CI = 2.65–6.24), considering the use of 
neurotrophic factors and cell grafts in those studies. Overall, we observed that the beneficial effects of alginate 
implantation on hindlimb function were swifter and more pronounced until 14 DPI. Spontaneous locomotor 
improvement observed in the first two weeks post injury has been attributed to recovery from initial spinal shock 
Figure 8. Inflammation. (a) Label-free multiphoton picture of a longitudinal section of a control sample 
at 28 DPI. (b) Label-free multiphoton picture of a longitudinal section of a treatment sample at 28 DPI. 
Magnifications show inflammatory cells. (c) Label-free multiphoton pictures of a longitudinal section of a 
control sample at 154 DPI, with magnification of the inflammatory cells in the dorsal median sulcus. CARS: 
red, TPEF: green, SHG: blue. (d) Quantification of area covered by fluorescent inflammatory cells in the injured 
area of longitudinal sections (mean ± SD, two-tailed t-test *P < 0.05). (e) Label-free multiphoton pictures of 
ipsilateral side of cross-sections located cranially and caudally to the lesion of a control sample at 154 DPI; the 
arrow indicates fluorescent inflammatory cells accumulating cranially in the dorsal median sulcus, and the 
arrowhead caudally near the ventral fissure; boxes indicate a region with presence of scattered inflammatory 
cells. (f) Quantification of fluorescent inflammatory cells in the ipsi- and contralateral white matter on cross-
sections at 154 DPI (mean ± SD, two-tailed t-test, **P < 0.01, ***P < 0.001). (g) Scatter plot of ipsilateral 
hindlimb functions vs. number of fluorescent inflammatory cells. BBB scores are the average of scores obtained 
for each animal between 70 and 154 DPI.
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and enhanced plasticity of the spared nervous tissue42,43. Treated animals performed significantly better compared 
to controls already in this early phase, suggesting that alginate intervenes already in the acute phase following SCI.
The presence of alginate implants strongly altered the morphology of the nervous tissue inside and around the 
injury. Alginate implants were associated with presence of larger cysts, but these had no adverse effects on hind-
limb functions. Rats underwent an anatomically complete disconnection between cranial and caudal parts of the 
ipsilateral side of spinal cord. All descending tracts important for gait (corticospinal, rubrospinal and descending 
serotonin pathways) were interrupted for a length of 2 mm. In both control and treatment group, we observed 
scarring or presence of cysts in the injured hemicord involving tissue until the midline in the chronic stage after 
SCI (as can be seen in Fig. 4). Therefore, the presence and localization of cysts was not considered to be substan-
tial for functional outcome of the ipsilateral hindlimb. In earlier studies, it was shown by using both stainings and 
vibrational spectroscopy24,25, that the alginate hydrogel used in this study is not fully degraded and remains in 
the cysts up to six months after implantation. We verified that the presence of the implant influenced fibrous scar 
morphology. The alginate-filled cysts were encapsulated by a layer of collagen that was thin and sometimes dis-
continuous. This observation confirmed earlier results obtained with non-functionalized calcium alginate hydro-
gel implants25,44. The glial scar surrounded the fibrous scar in all samples and was not altered by the treatment.
The hydrogel had positive effects on the amount of myelinated axons that were detected by CARS at the 
injury site, although massive ingrowth of axons in the hydrogel could not be demonstrated in agreement with 
earlier studies44. As collagen infiltrated also in the tissue surrounding the injury, it was not possible to discern 
by label-free multiphoton microscopy between spared axons at the border of injury and axons growing into the 
lesion. However, the long and thin tissue bridges crossing the large cystic cavities (observed in 5/7 treated ani-
mals both at 28 and 154 DPI) represent new tissue infiltrating within cracks of the implants. Axons within this 
tissue bridges represent axons that regrew after injury, as also confirmed by immunohistochemistry. In addition, 
the alignment observed between axons and collagen fibers in the lesion further support the idea that these are 
regrowing axons. Moreover, the correlation between axons in the lesion and hindlimb functions may indicate that 
at least a subpopulation of these axons had reconnected.
The data show that the orientation of collagen fibers was affected by alginate implantation: the fibers displayed 
a higher degree of longitudinal alignment in the major part of the samples of the treatment group. Axons in the 
lesion were mostly aligned with collagen fibers. Hence, the collagen meshwork might have worked as a guiding 
structure that helped axons to bridge the injury. Although the dense fibrotic scar that forms in the lesion after 
SCI serves as a binding matrix for several inhibitory molecules and is recognized as major impediment for axonal 
regeneration45–47, collagen type I does not inhibit axonal growth “per se”. Indeed, it was shown that collagen 
implants support the ingrowth of injured fibers in rat models of SCI48,49, and that properly oriented collagen fibers 
can act as scaffold for guiding axons across the lesion50.
Further beneficial effects of alginate hydrogel implants were observed on contralateral white matter demy-
elination. While myelin degradation of the ipsilateral white matter proceeded unaffected by the treatment in the 
intermediate phase, the level of demyelination in the contralateral white matter at the chronic stage was reduced in 
presence of implants. As demyelination was not observed one-month post injury in similarly treated rat models25, 
we hypothesize that the higher degree of axonal myelination of contralateral white matter is not attributed to 
remyelination, but rather to neuroprotective effects of alginate implants. Other studies evidenced contralateral 
white matter demyelination in the chronic injury phase after dorsal hemisection in rats51. The time point, when 
the decline of transmission through the contralateral white matter reached a maximum, marked also the end of 
locomotor recovery51, indicating that contralateral demyelination plays an important role in functional outcome.
Hydrogel implantation did not exacerbate the inflammatory response, in agreement with the generally 
accepted biocompatibility of commercial-grade (i.e., high purity) alginate14. The results of this study rather sug-
gest decreased inflammation. The implant prevented the accumulation of debris and infiltration of cells in the 
resection cavity, leading to a significantly lower amount of activated microglia and macrophages during the inter-
mediate phase. Similar distribution of inflammatory cells in control and alginate hydrogel implanted rats was 
observed in earlier studies44. The reduced inflammation might indicate reduced secondary damage, which cor-
relates with the swifter functional improvement observed in treated rats during the acute and sub-acute phases.
Residual inflammation was observed until a late injury phase, in accordance with earlier studies. Chronic 
alterations of spinal cord white matter after contusion injury in rats were observed 4 mm rostral and caudal to the 
injury epicenter 6 weeks after SCI, and included increased microglia/macrophages in the dorsal, lateral and ven-
tromedial regions52. Chronic inflammation with persistency of macrophages with foamy phenotype was observed 
in rats until 55 DPI53. Our results show that a similar distribution of activated cells with a phenotype consistent 
with foam cells remains also in a later stage of unresolved inflammation. Moreover, lower levels of inflammation 
outside the lesion in the chronic phase positively correlated with the improved functions. The role of inflamma-
tion is crucial for outcome after SCI54. Ongoing inflammation in the intermediate and chronic phase of SCI in 
rodents is dominated by neurotoxic M1-type macrophages55, which localize both at the lesion epicenter and in the 
area of axonal degeneration56, and was demonstrated to be highly detrimental for recovery57.
By using label-free multiphoton microscopy, we could simultaneously address three main issues after SCI: (i) 
presence and myelination of axons, (ii) amount and morphology of fibrotic scarring (iii) number and localization 
of inflammatory cells. A subset of morphochemical parameters visualized by multiphoton microscopy correlated 
with locomotor functions. Moreover, the intrinsic lack of tissue processing of our label-free approach enabled 
imaging of the fragile and tiny tissue bridges extending in the cystic cavities. The main limitation of the label-free 
multiphoton microscopy modalities used here is the incapability to address the glial scar. However, other similar 
techniques could fill this gap, such as stimulated Raman scattering, which enables visualization of astrocytic pro-
cesses based on selective chemical imaging of proteins58.
In conclusion, we analyzed the effects of soft calcium alginate hydrogel in a rat model of hemisection, and 
found that, even without any functionalization, the implants positively affected the sequence of events after injury. 
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Implant effects were primarily neuroprotective: contralateral demyelination and inflammation were reduced. 
The alginate hydrogel implants likely had also regeneration-promoting effects: the amount of myelinated and 
probably functional axons was increased in the lesion and clearly correlated with improved functions. Finally, 
the morphology of the fibrotic scar was deeply affected, possibly contributing to an environment that facilitated 
axonal bridging across the injury. Overall, we conclude that alginate hydrogel promotes a regeneration friendly 
environment after a massive spinal cord injury.
Methods
Ethics statement and animal care. All animal experiments were performed in accordance with the guide-
lines of the TU Dresden, based on national laws in full agreement with the European Union directive on animal 
experiments. They were approved by the Regional Council (Landesdirektion Sachsen, Germany, AZ 24–9168.11-
1/2013-37). All efforts were made to minimize animal suffering. The analgesic carprofen (5 mg/kg; Veicore Ltd, 
UK) and a prophylactic antibiotic (Duphamox LA 15 mg/kg; Fort Dodge Veterinär GmbH, Germany) were given 
preoperatively. Surgery was performed on rats anesthetized with an intraperitoneal injection of xylazine/keta-
mine (10 mg/kg xylazine; 90 mg/kg ketamine). In the first two postoperative days, analgesia was achieved with 
carprofen (5 mg/kg s.c.) once a day subcutaneously. Rarely, buprenorphine (0.05 mg/kg s.c.) was given for addi-
tional analgesia. Injured animals received daily care.
Alginate hydrogel. Pronova ultrapure sodium alginate (Novamatrix, Sandvika, Norway), containing 50% 
mannuronate, was used to prepare the hydrogel. Sterile filtrated 4% alginate solution was produced. The alginate 
hydrogel was prepared by overlaying the sol with a crosslinking solution of CaCl2 and NaCl for 12 h at room 
temperature. The shear storage modulus of the obtained hydrogel was G’ = 0.195 kPa. Further details about prepa-
ration and rheology are reported elsewhere25.
Animal experiments. Female Wistar rats (n = 42), aged 16 weeks and weighting between 200 g and 250 g, 
were used. A left-sided hemisection of the spinal cord at the level T9-T10 of the thoracic vertebrae was surgically 
induced under a surgical microscope. The left side of the spinal cord was dissected along a medial longitudinal 
plane for a length of 2 mm as described earlier25,59. Randomly selected rats (n = 21) received a soft calcium alginate 
hydrogel into the lesion. The blocks of alginate hydrogel with dimension approximately 2 mm × 2 mm × 1.5 mm 
(medio-lateral × rostro-caudal × dorso-ventral, corresponding to a volume of ∼6 mm3) were manually cut 
and placed in the hemisection immediately after injury induction. The remaining rats (n = 21) did not receive 
any implant and were used as control. The rats were sacrificed at 28 days post injury - DPI (treatment group: 
n = 7, control group: n = 7) or at 154 DPI (treatment group: n = 14, control group: n = 14). The animals were 
perfusion-fixed using 4% paraformaldehyde in TRIS-buffered saline, the spinal cords were isolated and cryopro-
tected in rising sucrose concentration (10% for 24 h and 30% for 24 h). A ∼20 mm long portion of the spinal cord 
with the lesion roughly in the center was embedded in tissue freezing medium (Leica, Nussloch, Germany) and 
frozen on dry ice. Finally, 16 μm thick cryosections were prepared. Longitudinal sections were obtained from all 
rats sacrificed at 28 DPI and half of the rats at 154 DPI (treatment group: n = 7, control group: n = 7); transverse 
cross-sections were obtained from the remaining rats at 154 DPI (treatment group: n = 7, control group: n = 7). 
Cryosections were stored at −20 °C until use.
Behavioral tests. Beginning 10 days prior to surgery, all rats were trained twice daily to facilitate the accom-
modation to the open field. After surgery, hindlimb functionality was assessed in open field at 3, 7, 14, 21, 28 
DPI and afterwards every 14 days until 154 DPI. The rats were placed for 4 minutes onto the center of an area 
100 cm × 100 cm large with smooth non-slippery surface, and the locomotor functions assessed using the Basso, 
Beattie and Bresnahan (BBB) rating scale60. The scores were determined as an average of two observers and blind 
scoring ensured that observers were not aware of the animal’s treatment. A third observer that was not blinded 
filmed the session. In case of deviating scores given by the two observers, the video was analyzed and the best 
achieved BBB score was assigned.
Histology. The sections were fixed in methanol–acetone (1:1) for 10 min at −20 °C.
For HE staining, the sections were washed in distilled water, and incubated in Meyer’s hematoxylin/hemalum 
for 3 min. After washing in distilled water, the tissue was briefly destained in HCl–ethanol solution. Washing 
using tap water for 5 min was followed by 3 min staining in eosin (1% eosin G in 80% ethanol). The sections were 
dehydrated with rising ethanol concentrations, cleared in xylene and coverslipped using DePex.
Immunohistochemistry. Heat antigen retrieval in citrate buffer was performed followed by 0.3% TritonX 
for 15 min and blocking in 5% bovine serum albumin in PBS for 1 h. For GFAP immunohistochemistry, the 
tissue was probed with the antibody (Anti-GFAP-Cy3, 1:200, Sigma Aldrich) overnight at 4 °C. Rabbit anti- 
β-III-tubulin (1:500, Covance Inc., Princeton, NJ, USA), rabbit anti-Iba1 (1:200, Wako Chemicals GmbH, Neuss, 
Germany) and rabbit anti-GAP43 antibody (1:250, abcam, Cambridge, UK) were incubated overnight at 4 °C. 
After washing with PBS, sections were probed with fluorescent secondary antibodies (donkey anti-rabbit Alexa 
Fluor 594 (1:500, Invitrogen, Thermo Fisher Scientific, Waltham, MA, USA) at room temperature for 1 h. Stained 
fluorescent structures were visualized using a microscope Axio Examiner Z.1 equipped with camera AxioCam 
and metal halide lamp HXP 120c (Carl Zeiss AG, Jena, Germany), or by two-photon fluorescence using multi-
photon microscopy.
Measurement of the lesion volume. The volume of lesions was evaluated on image stacks of serial lon-
gitudinal HE stained sections using a Stereo Investigator Software module (MBF Bioscience, Williston, USA) on 
a microscope Axioplan 2 (Carl Zeiss Microscopy GmbH, Jena, Germany). One section every 160 µm was used to 
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create the stack (approx. 20 to 25 sections for each animal). The lesion volume was estimated using the Cavalieri 
method with grid size of 150 µm to measure the lesion area on each section. The lesion area was defined including 
the (cystic) cavities and surrounding scar. The efficiency of sampling was checked by estimation of coefficients of 
error, which varied between 0.017 and 0.041. Measurements were performed in a blinded fashion.
Multiphoton microscopy. The system was already described elsewhere61. Briefly, an upright micro-
scope Axio Examiner Z.1 was coupled to a laser scanning module LSM 7 (Carl Zeiss Microscopy GmbH, Jena, 
Germany) and controlled by the software ZEN 2010, Rel. 6.0. Two picosecond lasers (Femto Fiber pro NIR and 
TNIR, Toptica Photonics AG, Gräfelfing, Germany) emitting at 781 nm and 1005 nm respectively were used to 
simultaneously excite the SHG and TPEF signals, as well as the CARS signal of the symmetric stretching vibration 
of methylene groups (i.e., Raman band at 2850 cm–1). A W Plan-Apochromat 20×/1.0 objective was used. SHG 
and CARS were detected in transmission mode using 390 ± 9 nm and 640 ± 7 nm bandpass filters, respectively. 
Green endogenous TPEF was detected in reflection mode in the range 525 ± 25 nm, while red TPEF of Cy3 and 
Alexa Fluor 594 of immunohistochemical stained sections was acquired in the range 587.2 ± 22.5 nm. The single 
channel intensity images were acquired with 8 bit depth and combined as RGB images for presentation. The color 
coding of label-free images is the following: blue channel: SHG, green channel: endogenous TPEF, red chan-
nel: CARS. The color coding of images of labelled sections is the following: blue channel: SHG, green channel: 
endogenous TPEF, red channel: TPEF of Cy3 or Alexa Fluor 594. A tiling procedure provided by ZEN was used 
for acquisition of images larger than the field of view. Pixel dimension was set to 0.1 µm for single field of view 
images, to 0.2 µm for large stitched images of longitudinal sections, and to 0.3 µm for large stitched images of 
cross-sections. For label-free multiphoton imaging, the cryosections were rehydrated with PBS and coverslipped.
Analysis of multiphoton images. All image analysis was performed in Fiji62.
Fibrotic scarring was analyzed based on collagen fibers imaged by SHG. Single-channel SHG images of lon-
gitudinal sections were manually segmented to select the injured area and excluding the dura. Collagen fiber 
orientation in the lesion was retrieved using the Directionality tool of Fiji with local gradient orientation method. 
For each sample, the direction displayed by highest number of fibers was chosen and reported as absolute value 
of the angle to spinal cord longitudinal axis. The amount of fibrotic scarring was evaluated based on area covered 
by collagen fibers. SHG images of cross sections were manually segmented to include all spinal cord tissue, but 
excluding cystic spaces. Afterwards, intensities were adjusted using the auto min/max tool, and the percent area 
with the signal of interest was selected with triangle threshold filter. The value for each animal was obtained by 
averaging the area retrieved on two sections inside the lesion 1 mm apart from each other.
Evaluation of myelin morphology was performed by visual inspection of CARS images of longitudinal sec-
tions, using 12 fields of views of dimension 200 µm × 200 µm acquired in the tissue immediately around the 
lesion. Myelin morphology in each field of view was rated with a score from zero to three, corresponding to 
increasing levels of damage as imaged by CARS (0: normal white matter morphology with well aligned axons, 1: 
sporadic presence of myelin ovoidal fragments within axons; 2: massive presence of myelin ovoidal fragments and 
lipid droplets, with disturbed axonal alignment; 3: predominant lipid droplets and loss of axonal alignment). The 
scores were then averaged for each animal.
Axons inside the lesion were identified based on morphology shown by CARS images and manually counted 
in 12 fields of view of dimension 200 µm × 200 µm in the lesion region.
Quantification of contralateral white matter demyelination was performed on CARS images of cross sections, 
in a region of 240 × 450 μm2 in the close proximity to the gray matter on the contralateral side to the lesion. The 
intensity of the CARS signal was adjusted using the auto min/max tool and CARS intensity threshold was then 
determined using the triangle filter in order to select the myelin sheaths only. Based on this, a mask was created 
and applied onto the original CARS image. The CARS signal intensity was measured in the selected regions only, 
thus excluding the background signal coming from intra- and inter-axonal spaces devoid of myelin. The intensity 
of the CARS signal was measured and ratioed to the background CARS signal of each image individually, in order 
to correct for small variations of excitation power and collection efficiency. The quantification was performed on: 
i) two sections 1 mm apart both located inside the lesion, ii) two sections located 2 mm and 4 mm away from the 
lesion, both cranially and caudally. The values obtained inside the lesion as well as cranially and caudally to the 
lesion were then averaged.
Inflammation at the lesion site was quantified based on the area covered by fluorescent cells imaged by TPEF. 
Single-channel TPEF images of unstained longitudinal sections were manually segmented to select a region of the 
ipsilateral tissue roughly 4 mm long, including the lesion site and altered surrounding tissue, but excluding cystic 
spaces. Afterwards, intensities were adjusted using the auto min/max tool and the percent area with the signal of 
interest was selected with maximum entropy threshold filter, which allowed to select highly fluorescent structures 
consistent with activated immune cells excluding other low-fluorescent cells33.
Statistics. Statistics was performed using GraphPad Prism 6.05 (GraphPad Software, La Jolla, California, 
USA). Repeated measures one- or two-way ANOVA and Bonferroni post hoc t-test, two-tailed t-test or 
Mann-Whitney U-test were used. Results were considered statistically significant if P < 0.05. All statistics on 
data extracted from multiphoton images was performed on groups formed by 5 to 7 rats (being 7 the number of 
animals of each experimental group - see section “Animal Experiments”), as in some cases it was not possible to 
obtain data due to problems in tissue handling.
Data availability. The datasets generated and analyzed during the current study are available from the cor-
responding author on reasonable request.
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